Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06606925 · ClinicalTrials.gov registry record · NA
Determining Which Regions of the Brain Are Active During Flight Simulation at Separate Timepoints During Training
A NA study of Cognitive Performance, sponsored by The Geneva Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06606925: Recruiting NA study of Cognitive Performance, sponsored by The Geneva Foundation.
NCT06606925 is a NA study of Cognitive Performance that is actively recruiting participants, run by The Geneva Foundation. The registered enrollment target is 150 participants, above the 62-participant average among 6 other Cognitive Performance trials with a reported enrollment target (142% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06606925, a NA study of Cognitive Performance, is actively recruiting participants, sponsored by The Geneva Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective is to identify the cognitive circuits associated with military aviator performance by analyzing what anatomic regions of the brain are functionally "active" (neuronal circuit) while being performing virtual flight simulations, the Precision Instrument Control Task (PICT). The flight simulation test will be conducted at two separate timepoints while the subject is receiving a Functional Magnetic Resonance Imaging (fMRI) scan to evaluate which anatomic and functional brain function is associated with precise performance. By scanning at multiple time points we aim to quantify changes in functional and anatomic connectivity that occur throughout the course of training.
Primary Outcome
Assess the flight simulation scores of responses (reaction times and latency) to the anatomical and functional regions of the brain that react when performing corrective flight actions. This will occur by analyzing anatomical MRI and fMRI imaging data and correlate with simulator performance.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST fMRI with virtual reality flight simulator
Study Locations (1)
Texas
- Joint Base San Antonio - Randolph & Lackland - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2026-09-18 |
| Phase | NA |
What NCT06606925 shows while recruiting
NCT06606925 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 62-participant average among 6 other Cognitive Performance trials with a reported enrollment target (142% higher).
The record links to 1 condition, with Cognitive Performance appearing as the primary indexed condition, and to 1 intervention - of which fMRI with virtual reality flight simulator is the first listed.
NCT06606925 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06606925 about?
NCT06606925 is a clinical study titled "Determining Which Regions of the Brain Are Active During Flight Simulation at Separate Timepoints During Training". The overall objective is to identify the cognitive circuits associated with military aviator performance by analyzing what anatomic regions of the brain are functionally "active" (neuronal circuit) while being performing virtual flight simulations, the Precision Instrument Control Task (PICT). The f...
What is the current status of trial NCT06606925?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-09-19. Estimated completion is 2026-09-18.
What conditions does trial NCT06606925 study?
This clinical trial studies the following conditions: Cognitive Performance.
What interventions are being tested in trial NCT06606925?
The interventions under investigation include: fMRI with virtual reality flight simulator (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06606925?
This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06606925 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Performance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
RECRUITING · NA
-
Examining the Biological Factors That Affect Sleep Duration
COMPLETED
-
Intraoperative Blood Pressure and Cognitive Performance
COMPLETED
-
Cognitive Function and Cue-Reactivity Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI